# Gert Van Assche

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gert-van-assche/

## Facts

| Field | Value |
| --- | --- |
| Citations | 60,226 |
| Field | Inflammatory Bowel Disease |
| h-index | 111 |
| i10-index | 338 |
| OpenAlex ID | https://openalex.org/A5045465014 |
| ORCID iD | https://orcid.org/0000-0003-0401-4664 |
| Works | 1,209 |

## Researcher papers

Showing 12 of 15.

- [Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis](https://scholariq.org/papers/vedolizumab-as-induction-and-maintenance-therapy-for-ulcerative-colitis/)
- [Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease](https://scholariq.org/papers/influence-of-immunogenicity-on-the-long-term-efficacy-of-infliximab-in-crohn-s/)
- [Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target](https://scholariq.org/papers/selecting-therapeutic-targets-in-inflammatory-bowel-disease-stride-determining/)
- [Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management](https://scholariq.org/papers/second-european-evidence-based-consensus-on-the-diagnosis-and-management-of/)
- [The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management](https://scholariq.org/papers/the-second-european-evidence-based-consensus-on-the-diagnosis-and-management-of-2/)
- [Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis](https://scholariq.org/papers/ustekinumab-as-induction-and-maintenance-therapy-for-ulcerative-colitis/)
- [Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial](https://scholariq.org/papers/expanded-allogeneic-adipose-derived-mesenchymal-stem-cells-cx601-for-complex/)
- [The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations](https://scholariq.org/papers/the-second-european-evidence-based-consensus-on-the-diagnosis-and-management-of/)
- [Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines](https://scholariq.org/papers/imaging-techniques-for-assessment-of-inflammatory-bowel-disease-joint-ecco-and/)
- [Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial](https://scholariq.org/papers/ciclosporin-versus-infliximab-in-patients-with-severe-ulcerative-colitis/)
- [Development of the Crohnʼs disease digestive damage score, the Lémann score](https://scholariq.org/papers/development-of-the-crohn-s-disease-digestive-damage-score-the-lemann-score/)
- [Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD](https://scholariq.org/papers/primary-sclerosing-cholangitis-is-characterised-by-intestinal-dysbiosis/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)
- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.